Literature DB >> 22884375

An overview of international literature from cystic fibrosis registries. Part 4: update 2011.

Donatello Salvatore1, Roberto Buzzetti, Ermanno Baldo, Maria Lucia Furnari, Vincenzina Lucidi, Daniela Manunza, Italo Marinelli, Barbara Messore, Anna Silvia Neri, Valeria Raia, Gianni Mastella.   

Abstract

A total of 53 national cystic fibrosis (CF) patient registry studies published between July 2008 and November 2011 have been reviewed, focusing on the following topics: CF epidemiology, nutrition, microbiology, clinical complications, factors influencing diagnosis and lung disease, effects of socioeconomic status, therapeutic strategy evaluation, clinical trial methodology. The studies describe the clinical characteristics of CF patients, the incidence and prevalence of disease and role of gender gap, as well as the influence of socioeconomic status and environmental factors on clinical outcomes, covering a variety of countries and ethnic groups. Original observations describe patients as they get older, with special reference to the adult presentation of CF and long-term survival. Methodological aspects are discussed, covering the design of clinical trials, survival analysis, auxometry, measures of quality of life, follow up of lung disease, predictability of disease progression and life expectancy. Microbiology studies have investigated the role of selected pathogens, such as Burkholderia species and MRSA. Pulmonary exacerbations are discussed both as a factor influencing morbidity and an endpoint in clinical trials. Finally, some studies give insights on complications, such as CF-related diabetes and hemoptysis, and emerging problems, such as chronic nephropathy.
Copyright © 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22884375     DOI: 10.1016/j.jcf.2012.07.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  16 in total

1.  Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients.

Authors:  D Gensburger; S Boutroy; R Chapurlat; R Nove-Josserand; S Roche; M Rabilloud; I Durieu
Journal:  Osteoporos Int       Date:  2016-05-11       Impact factor: 4.507

2.  Nasal endoscopy and paranasal sinus computerised tomography (CT) findings in an Irish cystic fibrosis adult patient group.

Authors:  P Casserly; M Harrison; O O'Connell; N O'Donovan; B J Plant; P O'Sullivan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-24       Impact factor: 2.503

3.  Cystic fibrosis in Austria.

Authors:  Thomas Frischer; Ernst Eber; Helmut Ellemunter; Angela Zacharasiewicz; Ingrid Kaluza; Josef Riedler; Sabine Renner
Journal:  Wien Klin Wochenschr       Date:  2017-02-24       Impact factor: 1.704

4.  The Rapid Reduction of Infection-Related Visits and Antibiotic Use Among People With Cystic Fibrosis After Starting Elexacaftor-Tezacaftor-Ivacaftor.

Authors:  Aaron C Miller; Logan M Harris; Joseph E Cavanaugh; Mahmoud Abou Alaiwa; David A Stoltz; Douglas B Hornick; Philip M Polgreen
Journal:  Clin Infect Dis       Date:  2022-09-30       Impact factor: 20.999

Review 5.  Background and Epidemiology.

Authors:  Don B Sanders; Aliza K Fink
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

6.  Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.

Authors:  Lucie Amoureux; Julien Bador; Sakina Fardeheb; Cédric Mabille; Charlyne Couchot; Clémence Massip; Anne-Lise Salignon; Guillaume Berlie; Véronique Varin; Catherine Neuwirth
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

Review 7.  Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases.

Authors:  Adriana Haack; Giselle Gonçalves Aragão; Maria Rita Carvalho Garbi Novaes
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

8.  Does current reporting of lung function by the UK cystic fibrosis registry allow a fair comparison of adult centres?

Authors:  Julia Anne Nightingale; Clive Osmond
Journal:  J Cyst Fibros       Date:  2017-04-24       Impact factor: 5.482

9.  [Factors impacting the growth and nutritional status of cystic fibrosis patients younger than 10 years of age who did not undergo neonatal screening].

Authors:  Taís Daiene Russo Hortencio; Roberto José Negrão Nogueira; Fernando Augusto de Lima Marson; Gabriel Hessel; José Dirceu Ribeiro; Antônio Fernando Ribeiro
Journal:  Rev Paul Pediatr       Date:  2015-02-11

10.  The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention.

Authors:  Thomas H Hampton; Deanna M Green; Garry R Cutting; Hilary G Morrison; Mitchell L Sogin; Alex H Gifford; Bruce A Stanton; George A O'Toole
Journal:  Microbiome       Date:  2014-04-28       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.